| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $322.7M | +13.8% |
| Cost of Revenue | $191.8M | +8.8% |
| Gross Profit | $130.9M | +22.1% |
| R&D Expense | $53.9M | +10.4% |
| SG&A Expense | $116.7M | +32.4% |
| Operating Income | -$91.1M | -23.2% |
| Pre-tax Income | -$70.0M | -34.8% |
| Income Tax | -$8.4M | -3.2% |
| Net Income | -$60.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.2M | -9.0% |
| Accounts Receivable | $84.8M | +22.8% |
| Current Assets | $550.5M | +55.7% |
| Total Assets | $1.21B | -0.5% |
| Current Liabilities | $85.0M | +16.6% |
| Total Liabilities | $106.8M | +17.6% |
| Stockholders' Equity | $1.11B | -1.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$101.6M | -582.6% |
| Capital Expenditures | $22.6M | -44.0% |
| Investing Cash Flow | $111.4M | +290.9% |
| Financing Cash Flow | -$14.8M | -205.1% |
| Free Cash Flow | -$124.2M | -545.1% |
| -41.7% |